Despair fuels hope ...

Flow cytometry continues to evolve, yet many experiments are still limited by avoidable issues in panel design, control selection, reagent handling, and instrument understanding. As analytical ...

Clostridioides difficile infection (CDI) is a major cause of healthcare-associated colitis, leading to severe illness, ...

IMU’s AI platform unlocks unprecedented immune insights for cancer and other diseases, measuring 100M+ data points from a ...

A large body of research publications covering hematological disorders, such as acute myeloid leukemia (AML) and multiple myeloma (MM), demonstrates that measurable minimal disease (MRD) neg ...

Henny Zijlstra, Chief Commercial Officer of Ardena, discusses the integrated CDMO model, Ardena’s new laboratory in New ...

Waters Corporation (NYSE: WAT) and IMU Biosciences have formed a strategic partnership to advance an AI-powered immune ...

IMU Biosciences partners with Waters to advance IMU’s AI-driven immunology platform to transform diagnosis and monitoring: London, UK Friday, June 26, 2026, 12:00 Hrs [IST] IMU ...

Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global ...

KATY, TX / ACCESS Newswire / July 6, 2026 / In the fields of life sciences and pharmaceutical R&D, primary cells retain ...